In contrast, Buitrago‐Molina et al24 found that SESN2 compensated loss of the cyclin‐dependent kinase inhibitor p21gene as the oncogenic factor to promote HCC development via Nrf2 in mice. Here, SESN2 is linked to hepatocellular carcinoma.